H. Graeff
- Cancer Research top 0.2%
- Protease and Inhibitor Mechanisms 64
- Immunology and Allergy top 0.5%
- Cell Adhesion Molecules Research 18
- Hematology top 0.5%
- Blood Coagulation and Thrombosis Mechanisms 45
- Oncology top 1%
- Peptidase Inhibition and Analysis 20
- Genetics top 1%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 25
-
- Blood properties and coagulation 31
-
- Pregnancy and preeclampsia studies 12
-
- Ovarian cancer diagnosis and treatment 11
- Journals
- Thrombosis and Haemostasis (12 papers)Thrombosis Research (12 papers)Journal of Molecular Medicine (9 papers)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
H. Graeff
201 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 4.0k
- Immunology and Allergy 1.1k
- Hematology 1.6k
- Oncology 2.2k
- Genetics 605
Countries citing papers authored by H. Graeff
This map shows the geographic impact of H. Graeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Graeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Graeff more than expected).
Fields of papers citing papers by H. Graeff
This network shows the impact of papers produced by H. Graeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Graeff. The network helps show where H. Graeff may publish in the future.
Co-authorship network
The 25 scholars most cited alongside H. Graeff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 1 | |
| 2 | 1999 | 35 | |
| 3 | 1998 | 45 | |
| 4 | 1997 | 2 | |
| 5 | 1997 | 16 | |
| 6 | 1997 | 44 | |
| 7 | 1996 | 188 | |
| 8 | Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2. | 1995 | 85 |
| 9 | 1994 | 6 | |
| 10 | 1994 | 12 | |
| 11 | 1993 | 298 | |
| 12 | 1991 | 0 | |
| 13 | 1991 | 5 | |
| 14 | 1991 | 202 | |
| 15 | 1990 | 23 | |
| 16 | 1989 | 2 | |
| 17 | 1989 | 1 | |
| 18 | 1988 | 8 | |
| 19 | 1987 | 4 | |
| 20 | [Pathomechanisms, signs, symptoms and management of amniotic fluid embolism (author's transl)]. | 1978 | 4 |
About H. Graeff
H. Graeff is a scholar working on Cancer Research, Hematology and Immunology and Allergy, having authored 210 papers that have together received 7.5k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (64 papers), Blood Coagulation and Thrombosis Mechanisms (45 papers), Blood properties and coagulation (31 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (25 papers), Peptidase Inhibition and Analysis (20 papers), Cell Adhesion Molecules Research (18 papers), Pregnancy and preeclampsia studies (12 papers) and Ovarian cancer diagnosis and treatment (11 papers). The work is most often cited by research in Cancer Research (4.0k citations), Immunology and Allergy (1.1k citations) and Hematology (1.6k citations). H. Graeff has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Manfred Schmitt, F. Jänicke, Nadia Harbeck, Olaf G. Wilhelm, Kurt Ulm, W. Kühn, R. Hafter, L. Pache, Heinz Höfler and Markus Schwaiger. Their work appears in journals such as Thrombosis and Haemostasis, Thrombosis Research, Journal of Molecular Medicine, International Journal of Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.